Laurie J. Hall Trustee’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Laurie J. Hall Trustee’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-520	Closed	-$3K	–	337
2019 Q3	$3K	Hold	520	–	–	﹤0.01%	312
2019 Q2	$3K	Hold	520	–	–	﹤0.01%	317
2019 Q1	$2K	Hold	520	–	–	﹤0.01%	330
2018 Q4	$2K	Sell	520 -100	-16%	-$509	﹤0.01%	327
2018 Q3	$4K	Hold	620	–	–	﹤0.01%	337
2018 Q2	$5K	Hold	620	–	–	﹤0.01%	328
2018 Q1	$5K	Hold	620	–	–	﹤0.01%	323
2017 Q4	$4K	Sell	620 -300	-33%	-$1.82K	﹤0.01%	335
2017 Q3	$6.77K	Hold	920	–	–	﹤0.01%	272
2017 Q2	$6.25K	Hold	920	–	–	﹤0.01%	277
2017 Q1	$7.94K	Hold	920	–	–	0.01%	255
2016 Q4	$8K	Buy	+920	New	+$6.8K	0.01%	257
2016 Q2	$5K	Buy	+920	New	+$4.44K	﹤0.01%	271

Other funds holding PGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Laurie J. Hall Trustee's PGNX Position: Q4 2019 in Review

Laurie J. Hall Trustee sold out of Progenics Pharmaceuticals Inc (PGNX) in Q4 2019, closing a stake of 520 shares — an estimated $3K sold.

Laurie J. Hall Trustee first reported a position in PGNX in Q2 2016 and held it in 13 quarters. The position peaked at $8K in Q4 2016. 128 funds tracked by Wall St. Rank hold PGNX as of Q4 2019.

Laurie J. Hall Trustee reported no remaining Progenics Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
Laurie J. Hall Trustee sold 520 Progenics Pharmaceuticals Inc shares in Q4 2019, an estimated $3K.
Laurie J. Hall Trustee first reported a position in Progenics Pharmaceuticals Inc in Q2 2016 and held it in 13 quarters.
Laurie J. Hall Trustee's Progenics Pharmaceuticals Inc position peaked at $8K in Q4 2016.
128 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q4 2019.

Based on Laurie J. Hall Trustee's 13F filing for Q4 2019, filed 12 Feb 2020.